The question
Does restoring NAD and sirtuin activity generally slow ageing?
This is the specific idea being tested.
The Hypothesis Critic · A guide for everyone
NAD+/Sirtuin Aging Hypothesis
Does restoring NAD and sirtuin activity generally slow ageing?
What you need to knowNAD-related changes involve several pathways. They do not establish a general human anti-ageing benefit.Relative explanatory fit: Alternative ranked ahead
Why the alternative fits better: NAD treatments change metabolism and repair without proving one NAD-to-sirtuin route controls ageing.
Review summary
Claim assessed: Age-related NAD+ decline limits sirtuin activity and is a causal driver of organismal aging, so NAD+ precursor repletion restores youthful function and improves human healthspan or lifespan.
Finding: Preregistered weakest-link returns Β because SC1 is scored at association/existence level; SC2 and bounded functional SC3 reach Ε, and general primacy SC4 is Γ. This conservative aggregation is preserved even though it can understate the strength of narrower causal contributions. The named primary subclaim SC3 returns Ε for the measured human functional scope. Scope-matched returns Γ: only SC4 carries the central claim's general organismal-aging scope, while SC3 is restricted to baseline-defined trial populations and is reported separately. Neither sensitivity establishes human lifespan or general aging reversal.
Key points
- SC1: NAD+ levels decline with age in multiple tissues. — HSEF Β, Moderate confidence.
- SC2: NAD+ decline causally contributes to age-related dysfunction through sirtuin-dependent mechanisms. — HSEF Ε, Moderate confidence.
- SC3: NR or NMN repletion improves human clinical healthspan or lifespan. — HSEF Ε, Moderate confidence.
- SC4: Sirtuins act as general longevity regulators rather than context-specific metabolic response proteins. — HSEF Γ, Moderate confidence.
Verdict and review details
- Evidence grade
- HSEF Β — Associational
- Confidence
- Moderate
- Framework
- HSEF v5.3
- Review date
- Published
- Review attribution (recorded)
- Codex
Evidence scope: 60 primary reports; cutoff 2026-10-04; bounded critical review, not exhaustive systematic review.
The grade applies to the stated claim. Model rankings and individual subclaim grades remain separate from the overall causal-evidence grade.
Full scientific assessment and references · Scorecard (JSON) · Review source (Markdown)
The result at a glance
NAD-related changes involve several pathways. They do not establish a general human anti-ageing benefit.
Read the labels in this illustration
THE MAIN FINDING NAD-related changes involve several pathways. They do not establish a general human anti-ageing benefit. The idea Does restoring NAD and sirtuin activity generally slow ageing? Restore NAD and sirtuins One route controls ageing Slower human ageing Proposed chain — plausible, not established What fits better Several nutrient and repair pathways Best fit in this review dashed line: proposed relationship NAD+ (a cellular cofactor) Metabolism DNA repair Sirtuins (bounded) NAD touches several routes (proposed links, dashed) single-driver claim not established NAD treatments change metabolism and repair without proving one NAD-to-sirtuin route controls ageing. What remains uncertain Which of NAD's effects actually matter for ageing Whether sirtuins are drivers or bounded stress sensors What NAD treatments do to meaningful human outcomes Evidence comes from cells, animals, and people — each setting carries different weight. NAD participates in many pathways at once. That breadth is exactly why one NAD-to-sirtuin route cannot be credited with controlling ageing. Conceptual illustration
Best fit in this review
Several nutrient and repair pathways
NAD treatments change metabolism and repair without proving one NAD-to-sirtuin route controls ageing.
Evidence for the stated claim
Association only
A higher rank means a better fit to the evidence in this comparison. It does not prove every part of the leading explanation.
Which explanation fits?
Another explanation fits better.
A separate question from the causal evidence grade
How does this explanation compare with alternatives?
Alternative ranked aheadThe reviewed hypothesis ranks 5 among 5 models compared; 1 alternative model(s) hold first rank for this stated claim.
Claim under review: rank 5 among 5 compared models.
Leading explanation: Nutrient-sensing network primacy.
Position in this comparison: Last recorded rank.
The causal grade asks how well the stated causal claim is established. This comparison asks which of the assessed explanations fits the reviewed findings better. A leading explanation can remain unproven. Models can overlap or include the tested mechanism; an alternative ahead does not make that mechanism irrelevant. These ordinal ranks apply within this review; they do not measure the size of a difference or rank scientific strength across topics.
Read the labels in this illustration
TWO EXPLANATIONS, COMPARED A · The idea under review Does restoring NAD and sirtuin activity generally slow ageing? Proposed chain Restore NAD and sirtuins One route controls ageing Slower human ageing Each arrow is a proposal, not a proven step. NAD treatments change metabolism and repair without proving one NAD-to-sirtuin route controls ageing. B · Leading explanation Several nutrient and repair pathways Another explanation fits better NAD+ (a cellular cofactor) Metabolism DNA repair Sirtuins (bounded) NAD touches several routes (proposed links, dashed) Several routes, no single proven driver — proposed links are dashed A better fit is not proof of every part of the explanation. These explanations can overlap. Conceptual illustration
Idea being tested · rank 5
Does restoring NAD and sirtuin activity generally slow ageing?
Association only for the stated claim.
Best fit in this review · rank 1
Several nutrient and repair pathways
NAD treatments change metabolism and repair without proving one NAD-to-sirtuin route controls ageing.
These explanations can overlap. Ranking their fit to the evidence is separate from deciding how firmly a cause has been established.
See all the explanations compared
Rank 1: Nutrient-sensing network primacy — NAD interventions participate in multiple metabolic and repair pathways.
Rank 2: Senescence/CD38 degradation sink — Inflammatory senescence drives a modifiable NAD sink.
Rank 3: Sirtuins as bounded stress sensors — Particular sirtuins protect particular contexts.
Rank 4: Permissive redox-cofactor availability — NAD pools enable several necessary cellular reactions.
Rank 5: NAD decline/sirtuin primacy — Age-associated NAD loss initiates general aging through limited sirtuin activity.
What this means
?
Association only
NAD-related changes involve several pathways. They do not establish a general human anti-ageing benefit.
Evidence rating: Β · Moderate confidence. How the evidence was assessed.
The important distinction
NAD treatments change metabolism and repair without proving one NAD-to-sirtuin route controls ageing.
Health and treatment
This is an assessment of a causal explanation, not proof that a particular supplement, diet, test, or treatment improves health. A treatment claim needs studies that test the intervention in people and measure meaningful benefits and harms. These findings can help frame research and informed clinical questions, but they do not identify what is right for one person.
From an idea to an explanation
Seeing two things together does not prove one causes the other.
What is observed?
Look for the proposed factor and the outcome, in the people or systems covered by the claim.
What else explains it?
Several nutrient and repair pathways. NAD treatments change metabolism and repair without proving one NAD-to-sirtuin route controls ageing.
What test tells them apart?
Separate NAD's different effects, measuring meaningful ageing outcomes rather than a marker alone.
Key questions
The key parts of the idea
These illustrations show the key questions tested in the review. They are conceptual drawings, not microscope images or experimental results.
What to test next
What evidence would make the answer clearer?
Read the labels in this illustration
WHAT WOULD MAKE THE ANSWER CLEARER A research question Separate NAD's different effects, measuring meaningful ageing outcomes rather than a marker alone. then then Change the proposed cause Proposed test NAD raised, sirtuins active NAD raised, sirtuins blocked NAD unchanged (control) Sirtuin activity separated from other NAD effects — cells, animals, people. Measure the relevant outcome Proposed test Physical function Disease and healthspan NAD and sirtuin markers DNA repair activity Meaningful outcomes — not a marker alone. Check the result independently Proposed test First team measures Second team repeats An independent check of the result. Same measures, fresh eyes — no shared data until the end. This storyboard shows the logic of a test. It does not show a result. The question is which of NAD's effects matter — not just whether a marker moves. Conceptual illustration
A useful next question
Separate NAD's different effects, measuring meaningful ageing outcomes rather than a marker alone.
Change the proposed cause
Check that the intended change really happened.
Measure the relevant outcome
Allow for other factors and compare with suitable controls.
Check whether it holds up
Look for independent confirmation and the limits of the effect.
These are questions for research, not a claim that the proposed studies have already succeeded.
Read the scientific study designs
Proposed tests: 1 test design(s) are registered in the scorecard.
In plain terms, researchers would change the proposed cause, check that it changed as intended, then measure a meaningful outcome while controlling plausible alternatives. The result should be able to support or count against the claim—not only show that a pathway exists.
Experiment 1: Registered boundary experiment
Study design: In baseline-defined older adults, randomize adequate NR/NMN exposure and test prespecified clinical function/disability over meaningful follow-up. Pair this with an adult-selective mechanistic contrast that blocks the proposed sirtuin mediator while preserving NAD repletion and other NAD-dependent routes, with selective rescue and masked outcome assessment. Human exposure instruments or lifelong natural experiments can complement the mediator experiment.
What would be measured: Clinical function, disability, incident age-related disease and survival, separately from blood/tissue NAD and sirtuin activity
Important controls: Tissue engagement, age/sex/disease context, intake, co-interventions, multiplicity and mediation specificity; no responder-selected inference
Result that would support the claim: Replicated clinical aging benefit lost specifically with sirtuin blockade and restored by mediator rescue
Result that would count against it: Adequate engagement without clinical benefit, or preserved benefit when the nominal sirtuin mediator is removed
Explore the evidence
Read the complete scientific review.
Follow the studies, detailed comparisons and evidence ratings behind this guide.
Open the scientific review →